RachelB.WagmanMDFACE, FACP

Endocrinology • Brisbane, CA

Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine

Operational Vice President, Clinical Research

Join to view full profile

Dr. Wagman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wagman's full profile

Already have an account?

Office
Sumitomo Pharma America
2000 Sierra Point Parkway STE 900
Brisbane, CA 94005
Phone+1 650-534-4783

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2002
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1997 - 2000
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1997
University of PennsylvaniaBA, History, Distinction in History, 1989 - 1993

Certifications & Licensure

AZ State Medical License 2001 - 2025
CA State Medical License 2000 - 2025
IN State Medical License 2002 - 2025
PA State Medical License 1998 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Publications & Presentations

PubMed

77 citations
Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
Ayman Al-Hendy, Andrea S. Lukes, Alfred N. Poindexter, Roberta Venturella, Claudio Villarroel
The New England Journal of Medicine. 2021-02-18
51 citations
Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (...
Linda C Giudice, Sawsan As-Sanie, Juan C Arjona Ferreira, Christian M Becker, Mauricio S Abrao
Lancet. 2022-06-18
444 citations
Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded...
Jacques P. Brown, Richard L. Prince, Chad L. Deal, Robert R. Recker, Douglas P. Kiel
Journal of Bone and Mineral Research. 2009-01-01

Press Mentions

Single BMD and Fracture Hx May Predict Risk of Fracture in Postmenopausal WomenAugust 28th, 2017
Single BMD and Fracture Hx May Predict Risk of Fracture in Postmenopausal WomenAugust 28th, 2017

Industry Relationships

SVP Clinical Development, Clinical Development2019 - Present

External Links

Linked Inhttps://www.linkedin.com/in/rachel-wagman-2b3b86/